Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.

[1]  P. Roehe,et al.  Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge. , 2006, Vaccine.

[2]  C. Kensil,et al.  A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. , 2005, Vaccine.

[3]  P. Lambert,et al.  The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703. , 2005, FEMS immunology and medical microbiology.

[4]  E. Paraguai de Souza,et al.  Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins. , 2004, Vaccine.

[5]  G. Gosmann,et al.  Constituents from leaves of Quillaja brasiliensis , 2004, Natural product research.

[6]  P. Roehe,et al.  A Brazilian glycoprotein E-negative bovine herpesvirus type 1.2a (BHV-1.2a) mutant is attenuated for cattle and induces protection against wild-type virus challenge , 2002 .

[7]  P. Roehe,et al.  Construction and characterization of a glycoprotein E deletion mutant of bovine herpesvirus type 1.2 strain isolated in Brazil , 2002 .

[8]  D. Montefiori,et al.  QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. , 2001, Vaccine.

[9]  L. Kenne,et al.  Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina. , 2000, Carbohydrate research.

[10]  M. Singh,et al.  Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis. , 2000, Vaccine.

[11]  A. Osterhaus,et al.  In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components. , 2000, Vaccine.

[12]  P. Chapman,et al.  Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  E. Nardin,et al.  Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice. , 1999, Vaccine.

[14]  L. Kenne,et al.  Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina. , 1999, Carbohydrate research.

[15]  Ricardo San Martin,et al.  Industrial uses and sustainable supply ofQuillaja saponaria (Rosaceae) saponins , 1999, Economic Botany.

[16]  I. Barr,et al.  ISCOMs and other saponin based adjuvants. , 1998, Advanced drug delivery reviews.

[17]  C. Kensil,et al.  Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. , 1991, Journal of immunology.

[18]  Hind.  CONSTRUCTION AND CHARACTERIZATION OF A GLYCOPROTEIN E DELETION MUTANT OF BOVINE HERPESVIRUS TYPE 1 . 2 STRAIN ISOLATED IN BRAZIL , 2003 .

[19]  C. Kensil,et al.  Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. , 1995, Vaccine.

[20]  R. Higuchi,et al.  An acylated triterpenoid saponin from Quillaja saponaria , 1988 .